89 related articles for article (PubMed ID: 7652913)
1. Cytomegalovirus infection during heart transplantation: assessment of a therapeutic protocol without prophylaxis.
Decoene C; Pol A; Dewilde A; Wattre P; Prat A; Stankowiak C; Warembourg H
Transplant Proc; 1995 Aug; 27(4):2523. PubMed ID: 7652913
[No Abstract] [Full Text] [Related]
2. A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation.
Macdonald PS; Keogh AM; Marshman D; Richens D; Harvison A; Kaan AM; Spratt PM
J Heart Lung Transplant; 1995; 14(1 Pt 1):32-8. PubMed ID: 7727473
[TBL] [Abstract][Full Text] [Related]
3. Incidence and therapy of cytomegalovirus disease after liver transplantation.
Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
[No Abstract] [Full Text] [Related]
4. CMV infection after kidney transplantation in children.
Lehnert A; Niaudet P; Broyer M
Transplant Proc; 1996 Oct; 28(5):2805. PubMed ID: 8908068
[No Abstract] [Full Text] [Related]
5. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
6. CMV in kidney transplantation: a single center experience over 22 years.
Nashan B; Lück R; Kliem V; Brunkhorst R; Schlitt HJ; Klempnauer J
Clin Transpl; 1999; ():181-8. PubMed ID: 11038636
[TBL] [Abstract][Full Text] [Related]
7. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
Tenschert W; Gonnermann D; Meyer-Moldenhauer WH; Cremaschi L; Huland H
Transplant Proc; 1993 Dec; 25(6):3256-8. PubMed ID: 8266533
[No Abstract] [Full Text] [Related]
8. Cytomegalovirus infection and prophylaxis in heart transplantation.
Laske A; Gallino A; Carrel T; Niederhäuser U; von Segesser LK; Turina MI
Transplant Proc; 1993 Feb; 25(1 Pt 2):1427-8. PubMed ID: 8382870
[No Abstract] [Full Text] [Related]
9. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
De Santo LS; Romano G; Mastroianni C; Roberta C; Della Corte A; Amarelli C; Maiello C; Giannolo B; Marra C; Ragone E; Grimaldi M; Utili R; Scardone M; Cotrufo M
Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
12. Decreasing incidence of serious cytomegalovirus infection using gancyclovir prophylaxis in pediatric liver transplant patients.
Boudreaux JP; Hayes DH; Mizrahi S; Maggiore P; Blazek J; Dick D
Transplant Proc; 1993 Apr; 25(2):1872. PubMed ID: 8385825
[No Abstract] [Full Text] [Related]
13. A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
Nafar M; Pezeshki ML; Farrokhi F; Einollahi B; Pour-Reza-Gholi F; Firouzan A; Farhangi S
Transplant Proc; 2005 Sep; 37(7):3053-5. PubMed ID: 16213302
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection after liver transplantation using different prophylaxes.
Kornberg A; Grube T; Hommann M; Schotte U; Scheele J
Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539
[No Abstract] [Full Text] [Related]
15. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
[No Abstract] [Full Text] [Related]
16. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients.
Israni A; Krok K; Cohen D; Blumberg E; Bloom RD
Transplant Proc; 2004 Dec; 36(10):3019-24. PubMed ID: 15686685
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
[No Abstract] [Full Text] [Related]
18. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
Boucher A; Lord H; Collette S; Morin M; Dandavino R
Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir.
Paniagua MJ; Crespo-Leiro MG; De la Fuente L; Tabuyo T; Mosquera I; Cañizares A; Naya C; Fariña P; Juffé A; Castro-Beiras A
Transplant Proc; 2002 Feb; 34(1):69-70. PubMed ID: 11959189
[No Abstract] [Full Text] [Related]
20. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
